The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Reporting owner

Randhawa Simrat

Reporting owner CIK 0001992260 · EVP, Head of R&D

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Randhawa SimratRandhawa SimratRandhawa Simrat · November 14, 2025 · Exercise / conversion · Common StockRandhawa Simrat · November 14, 2025 · Exercise / conversion · Common StockRandhawa Simrat · November 14, 2025 · Exercise / conversion · Common StockRandhawa Simrat · November 13, 2025 · Exercise / conversion · Common StockRandhawa Simrat · November 13, 2025 · Exercise / conversion · Common StockNov 13, 2025Nov 14, 2025
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

5 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Nov 14, 2025Dianthus Therapeutics, Inc. /DE/Common StockRandhawa SimratExercise / conversion
Nov 14, 2025Dianthus Therapeutics, Inc. /DE/Common StockRandhawa SimratExercise / conversion
Nov 14, 2025Dianthus Therapeutics, Inc. /DE/Common StockRandhawa SimratExercise / conversion
Nov 13, 2025Dianthus Therapeutics, Inc. /DE/Common StockRandhawa SimratExercise / conversion
Nov 13, 2025Dianthus Therapeutics, Inc. /DE/Common StockRandhawa SimratExercise / conversion

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: Dianthus Therapeutics, Inc. /DE/DNTH · company listings
Randhawa SimratEVP, Head of R&D
Exercise / conversionCommon StockNon-derivative security · Code M31,25022.07Value: 689,687.5Currency not specifiedView ↗
Trade: Dianthus Therapeutics, Inc. /DE/DNTH · company listings
Randhawa SimratEVP, Head of R&D
Exercise / conversionCommon StockNon-derivative security · Code M37,49421.77Value: 816,244.38Currency not specifiedView ↗
Trade: Dianthus Therapeutics, Inc. /DE/DNTH · company listings
Randhawa SimratEVP, Head of R&D
Exercise / conversionCommon StockNon-derivative security · Code M40,28717.88Value: 720,331.56Currency not specifiedView ↗
Trade: Dianthus Therapeutics, Inc. /DE/DNTH · company listings
Randhawa SimratEVP, Head of R&D
Exercise / conversionCommon StockNon-derivative security · Code M3,52917.88Value: 63,098.52Currency not specifiedView ↗
Trade: Dianthus Therapeutics, Inc. /DE/DNTH · company listings
Randhawa SimratEVP, Head of R&D
Exercise / conversionCommon StockNon-derivative security · Code M83,9788.44Value: 708,774.32Currency not specifiedView ↗